The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation.
The origin of brown adipocytes arising in white adipose tissue (WAT) after cold acclimatization is unclear. Here, we demonstrate that several UCP1-immunoreactive brown adipocytes occurring in WAT after cold acclimatization have a mixed morphology (paucilocular adipocytes). These cells also had a mixed mitochondrioma with classic "brown" and "white" mitochondria, suggesting intermediate steps in the process of direct transformation of white into brown adipocytes (transdifferentiation). Quantitative electron microscopy disclosed that cold exposure (6 degrees C for 10 days) did not induce an increase in WAT preadipocytes. beta(3)-adrenoceptor-knockout mice had a blunted brown adipocyte occurrence upon cold acclimatization. Administration of the beta(3)-adrenoceptor agonist CL316,243 induced the occurrence of brown adipocytes, with the typical morphological features found after cold acclimatization. In contrast, administration of the beta(1)-adrenoceptor agonist xamoterol increased only the number of preadipocytes. These findings indicate that transdifferentiation depends on beta(3)-adrenoceptor activation, whereas preadipocyte recruitment is mediated by beta(1)-adrenoceptor. RT-qPCR experiments disclosed that cold exposure induced enhanced expression of the thermogenic genes and of genes expressed selectively in brown adipose tissue (iBAT) and in both interscapular BAT and WAT. beta(3)-adrenoceptor suppression blunted their expression only in WAT. Furthermore, cold acclimatization induced an increased WAT expression of the gene coding for C/EBPalpha (an antimitotic protein), whereas Ccna1 expression (related to cell proliferation) was unchanged. Overall, our data strongly suggest that the cold-induced emergence of brown adipocytes in WAT predominantly reflects beta(3)-adrenoceptor-mediated transdifferentiation.
Barbatelli
G
G
Department of Molecular Pathology and Innovative Therapies, Faculty of Medicine, University of Ancona (Politecnica delle Marche), Ancona, Italy.
Murano
I
I
Madsen
L
L
Hao
Q
Q
Jimenez
M
M
Kristiansen
K
K
Giacobino
J P
JP
De Matteis
R
R
Cinti
S
S
D052437:Adipocytes, Brown / Q000166:cytology / Q000502:physiology* / Q000648:ultrastructure; D052438:Adipocytes, White / Q000166:cytology / Q000502:physiology* / Q000648:ultrastructure; D058667:Adrenergic beta-3 Receptor Agonists; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000818:Animals; D022763:CCAAT-Enhancer-Binding Protein-alpha / Q000235:genetics / Q000502:physiology; D002454:Cell Differentiation / Q000502:physiology; D054338:Cell Transdifferentiation; D003080:Cold Temperature; D056750:Cyclin A1 / Q000235:genetics / Q000502:physiology; D004149:Dioxoles / Q000494:pharmacology; D005260:Female; D007150:Immunohistochemistry; D007473:Ion Channels / Q000502:physiology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008854:Microscopy, Electron; D024101:Mitochondrial Proteins / Q000502:physiology; D012313:RNA / Q000737:chemistry / Q000235:genetics; D022702:Receptors, Adrenergic, beta-3 / Q000502:physiology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D000071256:Uncoupling Protein 1
D058667:Adrenergic beta-3 Receptor Agonists; D000318:Adrenergic beta-Agonists; D022763:CCAAT-Enhancer-Binding Protein-alpha; C503747:Ccna1 protein, mouse; D056750:Cyclin A1; D004149:Dioxoles; D007473:Ion Channels; D024101:Mitochondrial Proteins; D022702:Receptors, Adrenergic, beta-3; C000604372:Ucp1 protein, mouse; D000071256:Uncoupling Protein 1; C076126:disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate; D012313:RNA